<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Multidisciplinary Cancer Investigation</title>
<title_fa>نشریه بین المللی چند تخصصی سرطان</title_fa>
<short_title>Multidiscip Cancer Investig</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mcijournal.com</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2476-4922</journal_id_issn>
<journal_id_issn_online>2538-1911</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/mci</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1396</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2017</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<volume>1</volume>
<number>Supplement Issue 1: Abstracts of International Tehran Breast Cancer Congress</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Novel Curcumin Nano Formulations for Breast
Cancer</title>
	<subject_fa></subject_fa>
	<subject>Materials Science and Nanomedicine</subject>
	<content_type_fa></content_type_fa>
	<content_type>Original/Research Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>Introduction: Curcumin is a natural yellow compound that is obtained from Curcuma&lt;br&gt;
longa. Curcumin is found in two forms of ketone and enol that in PH &gt; 8, enol form is&lt;br&gt;
predominant. In enol form, curcumin acts as a potent antioxidant by losing its proton and&lt;br&gt;
reduction of free radicals. However, curcumin has had very low dissolution in water and&lt;br&gt;
its ketone form has been predominant in acidic conditions (the PH of environment surrounding&lt;br&gt;
the tumor is acidic). In addition, degradation rate of curcumin by enzyme and&lt;br&gt;
its elimination from the bloodstream is very high. So, the antioxidants effects of curcumin&lt;br&gt;
in the body have had greatly reduce. Today, scientists have promising that nanoparticles of&lt;br&gt;
curcumin can to overcome at these problems. In this study, has used of a new curcuminalbumin&lt;br&gt;
Nano formulation and measured its effect on MCF 7 and PBMC cells.&lt;br&gt;
Materials and Methods: After making of curcumin- albumin Nano drug, anticancer effects&lt;br&gt;
of its have been examined by MTT and flow cytometry tests on MCF7 and PBMC&lt;br&gt;
cells.&lt;br&gt;
Results: The MTT test showed that in the first 24 hours, the antioxidant effect of free&lt;br&gt;
curcumin and Nano drug has been similar and after 48 hours, curcumin antioxidant properties&lt;br&gt;
has reduced but Nano drug antioxidant properties have not changed. For normal&lt;br&gt;
cells, the results were almost the same. Flow cytometry has shown that at 54 &amp;mu;mol concentration,&lt;br&gt;
free curcumin and Nano drug have led to 74% and 83% apoptosis in MCF 7 and&lt;br&gt;
survival value of PBMC was 84% and 92%, respectively.&lt;br&gt;
Conclusions: Nano-curcumin drug increase curcumin solubility in water and its stability&lt;br&gt;
in physiological and acidic conditions. These, have been able it to overcome the limitation&lt;br&gt;
of use of curcumin.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Curcumin, Albumin, Nano Drug, MCF7</keyword>
	<start_page>0</start_page>
	<end_page>0</end_page>
	<web_url>http://mcijournal.com/browse.php?a_code=A-10-33-37&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Zahra </first_name>
	<middle_name></middle_name>
	<last_name>Matluobi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846001055</code>
	<orcid>10031947532846001055</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Zuhair </first_name>
	<middle_name></middle_name>
	<last_name>Saraf Hasan</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846001056</code>
	<orcid>10031947532846001056</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Parisa </first_name>
	<middle_name></middle_name>
	<last_name>Amir Kalvanagh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846001057</code>
	<orcid>10031947532846001057</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
